248 related articles for article (PubMed ID: 27001434)
1. The expression profiles of the galectin gene family in colorectal adenocarcinomas.
Gopalan V; Saremi N; Sullivan E; Kabir S; Lu CT; Salajegheh A; Leung M; Smith RA; Lam AK
Hum Pathol; 2016 Jul; 53():105-13. PubMed ID: 27001434
[TBL] [Abstract][Full Text] [Related]
2. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
3. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
[TBL] [Abstract][Full Text] [Related]
4. Expression of GAEC1 mRNA and protein and its association with clinical and pathological parameters of patients with colorectal adenocarcinoma.
Wahab R; Gopalan V; Islam F; Mamoori A; Lee KT; Lu CT; Lam AK
Exp Mol Pathol; 2018 Feb; 104(1):71-75. PubMed ID: 29337242
[TBL] [Abstract][Full Text] [Related]
5. [Association of galectin-3 expression with biological behaviors of human colorectal carcinoma].
Zhang N; Ding YQ; Liang L
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1685-9. PubMed ID: 17259097
[TBL] [Abstract][Full Text] [Related]
6. Expression profiling of cancer-related galectins in acute myeloid leukemia.
El Leithy AA; Helwa R; Assem MM; Hassan NH
Tumour Biol; 2015 Sep; 36(10):7929-39. PubMed ID: 25953264
[TBL] [Abstract][Full Text] [Related]
7. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
8. [Galectin-1 expression in human colorectal carcinoma and its clinical significance].
Zhu XL; Liang L; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1331-4. PubMed ID: 17884770
[TBL] [Abstract][Full Text] [Related]
9. Analyzing epigenetic control of galectin expression indicates silencing of galectin-12 by promoter methylation in colorectal cancer.
Katzenmaier EM; Kloor M; Gabius HJ; Gebert J; Kopitz J
IUBMB Life; 2017 Dec; 69(12):962-970. PubMed ID: 29098769
[TBL] [Abstract][Full Text] [Related]
10. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of tumor necrosis factor-α is associated with advanced colorectal cancer stages.
Al Obeed OA; Alkhayal KA; Al Sheikh A; Zubaidi AM; Vaali-Mohammed MA; Boushey R; Mckerrow JH; Abdulla MH
World J Gastroenterol; 2014 Dec; 20(48):18390-6. PubMed ID: 25561807
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.
Islam F; Gopalan V; Pillai S; Lu CT; Kasem K; Lam AK
Genes Chromosomes Cancer; 2018 May; 57(5):240-251. PubMed ID: 29318692
[TBL] [Abstract][Full Text] [Related]
13. The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas.
St Hill CA; Farooqui M; Mitcheltree G; Gulbahce HE; Jessurun J; Cao Q; Walcheck B
BMC Cancer; 2009 Mar; 9():79. PubMed ID: 19267921
[TBL] [Abstract][Full Text] [Related]
14. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
15. Tissue and serum galectin-1 expression in patients with colorectal carcinoma.
Sheng TH; Rong LX; Li ZY; Bo J; Lei S
Hepatogastroenterology; 2012; 59(114):389-94. PubMed ID: 22353504
[TBL] [Abstract][Full Text] [Related]
16. The clinicopathological significance of REIC expression in colorectal carcinomas.
Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
18. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.
Furlan D; Sahnane N; Carnevali I; Cerutti R; Bertoni F; Kwee I; Uccella S; Bertolini V; Chiaravalli AM; Capella C
Hum Pathol; 2008 Oct; 39(10):1483-94. PubMed ID: 18619649
[TBL] [Abstract][Full Text] [Related]
20. Gab2 is a novel prognostic factor for colorectal cancer patients.
Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]